Cayman now offers multiplex immunoassay technology powered by Quansys Biosciences.
ANN ARBOR, MI June 20, 2019—Cayman now offers multiplex immunoassay technology powered by Quansys Biosciences. This line of fully quantitative Q-Plex™ multiplex ELISAs and chemiluminescent Q-View™ imagers provides a highly sensitive means to simultaneously measure multiple markers using a single sample. “Adding the Q-Plex™ arrays and Q-View™ imagers to our portfolio gives our customers access to an innovative multiplex technology,” said Jason Truskowski, Vice President of Sales and Marketing at Cayman. “These products are an easy-to-use, sensitive multiplex platform where researchers can purchase ready-made panels or request to have custom plates built.”
Available human analyte panels include:
- Angiogenesis Biomarkers (9-plex)
- ANG-2, FGF basic, HGF, IL-8, PDGF-BB, TIMP-1, TIMP-2, TNF-α, VEGF
- Cytokine Screen (16-plex)
- IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL-15, IL-17, IL-23, IFN-γ, TNF-α, TNF-β
- High Sensitivity Cytokine Screen (15-plex)
- IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, IL-15, IL-17, IL-23, IFN-γ, TNF-α, TNF-β
- Inflammatory Cytokines (9-plex)
- IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IFN-γ, TNF-α
- Female Hormone Screen (8-plex)
- Adiponectin, Cortisol, C-Peptide, E1G, FSH, HCGb, IL-6, IL-10
- MMPs (6-plex)
- MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13
Available mouse analyte panels include:
- Cytokine Screen (16-plex)
- IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-17, MCP-1, IFN-γ, TNFα, MIP-1α, GMCSF, RANTES
- Inflammatory Cytokines (14-plex)
- IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-6, IL-10, IL-12p70, IL-17, MCP-1, TNF-α, MIP-1α, GMCSF, RANTES
Q-Plex™ assay plates are built by adsorbing each distinct capture antibody in a defined array to the bottom of each well. High-quality reagents provided in each kit help ensure the accuracy of the results. These assays require analysis using the Q-View™ Imager LS or the Q-View™ Imager Pro. Both optimized imaging systems are available from Cayman and include a powerful, user-friendly image analysis software package that enables the user to capture, view, and analyze microplate images.
“By simplifying the simultaneous testing of multiple analytes, our multiplex ELISA technology yields better results than a traditional ELISA while still relying on the highly sensitive ELISA methodology you know and trust,” said Adam Brown, CEO of Quansys Biosciences. “Plus, when you leverage our Q-View™ data analyzing software, this system becomes a powerful tool for quantitative analysis and a cost-effective means for generating a meaningful data profile for your samples.”
Contact us at sales@caymanchem.com to request a quote or visit www.caymanchem.com to learn more about the Q-Plex™ multiplex ELISAs and Q-View™ chemiluminescent imagers.
About Cayman Chemical
Cayman Chemical Company helps make research possible by supplying scientists worldwide with biochemical tools used to understand cancer, neurochemistry, oxidative injury, endocrinology, atherosclerosis, and other human health challenges. Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others for use as research reagents and qualified standards. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination. In addition, we offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques. Cayman performs generic drug development and production in both Ann Arbor, Michigan and Neratovice, Czech Republic.
